Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02124694 · ClinicalTrials.gov registry record · NA

Iwankapiya-Healing: Historical Trauma Practice and Group IPT for American Indians

A NA study of Depression and PTSD, sponsored by University of New Mexi.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT02124694: Completed NA study of Depression and PTSD, sponsored by University of New Mexi.

NCT02124694 is a NA study of Depression and PTSD that has completed, run by University of New Mexi. The registered enrollment target is 84 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02124694, a NA study of Depression and PTSD, has completed, sponsored by University of New Mexi.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

This study will pilot an intervention that combines group Interpersonal Psychotherapy (IPT), an empirically-supported treatment, and the Historical Trauma and Unresolved Grief Intervention (HTUG), a Tribal Best Practice for American Indians. HTUG focuses on grief, depression, and trauma response resolution related to collective massive group trauma across generations, including the lifespan, for American Indians. We anticipate more positive responses to, and patient engagement in, the combined HTUG/IPT intervention than to IPT Only.

Primary Outcome

Scale commonly used in IPT studies to assess depressive symptoms and track change over time. The Ham -D24 (and other shorter versions) is a commonly used clinician-administered depression assessment scale. This HAM-D24 is a 24 item version that incorporates three new items that assess helplessness, hopelessness, and worthlessness. The measure is commonly used to rate the severity of, and change in, a patient's major depression. It includes 24 items rated on a scale from 0-2, 0-3, or 0-4, with a

Interventions

  • BEHAVIORAL HTUG

Study Locations (1)

New Mexico

  • University of New Mexico Department of Psychiatry Center for Rural and Community Behavioral Health - Albuquerque

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2013-04-22
Est. Completion 2018-01-24
Phase NA
University of New Mexi

76 total trials

What the finished NCT02124694 record still lists

NCT02124694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which HTUG is the first listed.

NCT02124694 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT02124694 about?

NCT02124694 is a clinical study titled "Iwankapiya-Healing: Historical Trauma Practice and Group IPT for American Indians". This study will pilot an intervention that combines group Interpersonal Psychotherapy (IPT), an empirically-supported treatment, and the Historical Trauma and Unresolved Grief Intervention (HTUG), a Tribal Best Practice for American Indians. HTUG focuses on grief, depression, and trauma response res...

What is the current status of trial NCT02124694?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2013-04-22. Estimated completion is 2018-01-24.

What conditions does trial NCT02124694 study?

This clinical trial studies the following conditions: Depression, PTSD, Grief, Interpersonal Relations.

What interventions are being tested in trial NCT02124694?

The interventions under investigation include: HTUG (BEHAVIORAL).

Who is sponsoring clinical trial NCT02124694?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02124694 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02124694's enrollment target sits among peer trials

84 366th of 679 higher than 312 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT02124694, the US trial registry maintained by the National Library of Medicine. NCT02124694 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.